Jane Street Group, LLC Fate Therapeutics Inc Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$29.67 - $60.28 $216,591 - $440,044	7,300 Added 100.0%	14,600 $566,000
Q4 2021 Feb 15, 2022	SELL	$47.84 - $64.34 $52,624 - $70,774	-1,100 Reduced 13.1%	7,300 $427,000
Q3 2021 Nov 16, 2021	SELL	$59.27 - $95.73 $100,759 - $162,741	-1,700 Reduced 16.83%	8,400 $498,000
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $416,950 - $573,624	6,200 Added 158.97%	10,100 $877,000
Q1 2021 May 18, 2021	BUY	$72.16 - $117.4 $281,424 - $457,860	3,900 New	3,900 $322,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $157M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.